Susquehanna International Group, LLP Lyra Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024
SELL
$0.26 - $6.25 $1,066 - $25,625
-4,100 Reduced 8.13%
46,300 $12,000
Q1 2024

May 07, 2024
BUY
$4.55 - $6.53 $229,320 - $329,112
50,400 New
50,400 $313,000
Q4 2022

Feb 14, 2023
SELL
$2.44 - $5.42 $3,416 - $7,588
-1,400 Reduced 10.69%
11,700 $36,000
Q3 2022

Nov 14, 2022
BUY
$4.95 - $6.6 $64,845 - $86,460
13,100 New
13,100 $66,000

Others Institutions Holding LYRA

# of Institutions
62
Shares Held
32.2M
Call Options Held
21.1K
Put Options Held
400
View Full List

About Lyra Therapeutics, Inc.

LYRA Quotes by TradingView
  • Ticker LYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,826,400
  • Market Cap $5.73M
  • Description
  • Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...
More about LYRA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email